Dendritic/JJ
cells/NNS
and/CC
the/DT
pathogenesis/NN
of/IN
rheumatoid/JJ
arthritis/NN
./.

Rheumatoid/JJ
arthritis/NN
(/(
RA/NN
)/)
is/VBZ
a/DT
chronic/JJ
autoimmune/JJ
inflammatory/JJ
disease/NN
in/IN
which/WDT
unknown/JJ
arthrogenic/JJ
autoantigen/NN
is/VBZ
presented/VBN
to/TO
CD4+/JJ
T/NN
cells/NNS
./.
=====
The/DT
strong/JJ
association/NN
of/IN
the/DT
disease/NN
with/IN
an/DT
epitope/NN
within/IN
the/DT
HLA-DR/NN
chain/NN
shared/VBN
between/IN
various/JJ
alleles/NNS
of/IN
HLA-DR4/NN
and/CC
DR1/NN
emphasizes/VBZ
the/DT
importance/NN
of/IN
antigen/JJ
presentation/NN
./.
=====
This/DT
immune/JJ
response/NN
predominantly/RB
occurs/VBZ
in/IN
the/DT
synovial/NN
tissue/NN
and/CC
fluid/NN
of/IN
the/DT
joints/NNS
and/CC
autoreactive/JJ
T/NN
cells/NNS
are/VBP
readily/RB
demonstrable/JJ
in/IN
both/CC
the/DT
synovial/JJ
compartment/NN
and/CC
blood/NN
./.
=====
Circulating/VBG
dendritic/JJ
cells/NNS
(/(
DC/NN
)/)
are/VBP
phenotypically/RB
and/CC
functionally/RB
identical/JJ
with/IN
normal/JJ
peripheral/JJ
blood/NN
(/(
PB/NN
)/)
DC/NN
./.
=====
In/IN
the/DT
synovial/JJ
tissue/NN
,/,
fully/RB
differentiated/VBN
perivascular/JJ
DC/NN
are/VBP
found/VBN
in/IN
close/JJ
association/NN
with/IN
T/NN
cells/NNS
and/CC
with/IN
B/NN
cell/NN
follicles/NNS
,/,
sometimes/RB
containing/VBG
follicular/JJ
DC/NN
./.
=====
These/DT
perivascular/JJ
DC/NN
migrate/VBP
across/IN
the/DT
activated/VBN
endothelium/NN
from/IN
blood/NN
and/CC
receive/VBP
differentiative/JJ
signals/NNS
within/IN
the/DT
joint/NN
from/IN
monocyte-derived/JJ
cytokines/NNS
and/CC
CD40-ligand+/JJ
T/NN
cells/NNS
./.
=====
In/IN
the/DT
SF/NN
,/,
DC/NN
manifest/VBP
an/DT
intermediate/JJ
phenotype/NN
,/,
similar/JJ
to/TO
that/DT
of/IN
monocyte-derived/JJ
DC/NN
in/FW
vitro/FW
./.
=====
Like/IN
a/DT
delayed-type/JJ
hypersensitivity/NN
response/NN
,/,
the/DT
rheumatoid/JJ
synovium/NN
represents/VBZ
an/DT
effector/NN
site/NN
./.
=====
DC/NN
at/IN
many/JJ
effector/NN
sites/NNS
have/VBP
a/DT
characteristic/JJ
pattern/NN
of/IN
infiltration/NN
and/CC
differentiation/NN
./.
=====
It/PRP
is/VBZ
important/JJ
to/TO
note/VB
that/IN
the/DT
effector/NN
response/NN
is/VBZ
not/RB
self-limiting/JJ
in/IN
RA/NN
autoimmune/JJ
inflammation/NN
./.
=====
In/IN
this/DT
article/NN
,/,
we/PRP
argue/VBP
that/IN
the/DT
presentation/NN
of/IN
self-antigen/NN
by/IN
DC/NN
and/CC
by/IN
autoantibody-producing/JJ
B/NN
cells/NNS
is/VBZ
critical/JJ
for/IN
the/DT
perpetuation/NN
of/IN
the/DT
autoimmune/JJ
response/NN
./.
=====
Permanently/RB
arresting/VBG
this/DT
ongoing/JJ
immune/JJ
response/NN
with/IN
either/CC
pharmaceutical/JJ
agents/NNS
or/CC
immunotherapy/NN
is/VBZ
a/DT
major/JJ
challenge/NN
for/IN
immunology/NN
./.